Green nanotechnology developed at the University of Missouri is being used to explore new treatment options for breast cancer, according to a new article from the University of Missouri School of Medicine. India-based health innovation company Dhanvantari Nano Ayushadi (DNA) is using the Missouri-developed nanotechnology with the goal of making a traditional form of holistic medicine more effective at fighting cancer.
A research team from the University of Missouri helped develop green nanotechnologies to produce phytonano medicines, which are compounds that form the basis for Ayurvedic medicine. Ayurvedic medicine is a form of holistic medicine that uses a combination of chemicals derived from natural herbs, spices, fruits and vegetables, coupled with various metals such as gold, silver and copper.
“Our green nanotechnology approach for silver-based antibiotics and anti-infectives has produced a new generation of antimicrobial/antibiotics and anti-fungal products for household use, in hospitals and other health care sectors,” said Deepak Abhaya, general manager of DNA. “Our products decontaminate kitchens, operation theaters and various food particles, thus destroying drug-resistant deadly bacteria, microbes and fatal pathogens.”
Check out the full article from the University of Missouri here.
For more information on Missouri’s health innovation industry check out our webpage, or contact Steve Johnson, CEO of Missouri Partnership, at 314.725.2688 or via our contact form. He will answer any questions you might have, and explain how Missouri Partnership can help with your business expansion and investment needs.